HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amir Baghbanzadeh Selected Research

Immune Checkpoint Proteins

9/2022The potential of B7-H6 as a therapeutic target in cancer immunotherapy.
5/2022Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside.
4/2021Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment.
12/2020Molecular mechanisms of breast cancer chemoresistance by immune checkpoints.
9/2020Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amir Baghbanzadeh Research Topics

Disease

40Neoplasms (Cancer)
09/2022 - 01/2019
5COVID-19
10/2022 - 01/2020
5Neoplasm Metastasis (Metastasis)
06/2022 - 01/2019
5Breast Neoplasms (Breast Cancer)
01/2022 - 03/2020
4Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 01/2020
4Inflammation (Inflammations)
08/2021 - 01/2020
3Triple Negative Breast Neoplasms
10/2021 - 03/2020
3Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 01/2021
3Melanoma (Melanoma, Malignant)
04/2021 - 01/2021
2Carcinogenesis
09/2022 - 09/2020
2Stomach Neoplasms (Stomach Cancer)
01/2022 - 09/2020
2Microsatellite Instability
11/2021 - 01/2020
2Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 03/2019
1Autoimmune Diseases (Autoimmune Disease)
03/2022
1Ischemia
02/2022
1Atherosclerosis
02/2022
1Infections
12/2021
1Asthenozoospermia
12/2021
1Communicable Diseases (Infectious Diseases)
12/2021
1Teratozoospermia
12/2021
1Rheumatoid Arthritis
08/2021
1Behcet Syndrome (Behcet's Syndrome)
08/2021
1Connective Tissue Diseases (Connective Tissue Disease)
08/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2021
1Systemic Scleroderma (Systemic Sclerosis)
08/2021
1Vasculitis (Vasculitides)
08/2021
1Adenocarcinoma
06/2021
1Echinococcosis (Hydatid Cysts)
04/2021
1Multiple Myeloma
01/2021
1Alopecia (Baldness)
01/2021
1Kidney Neoplasms (Kidney Cancer)
01/2021
1Infertility (Sterility)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2021
1Osteoarthritis
01/2021
1Thrombosis (Thrombus)
10/2020

Drug/Important Bio-Agent (IBA)

14MicroRNAs (MicroRNA)IBA
01/2022 - 01/2019
7Immune Checkpoint InhibitorsIBA
05/2022 - 09/2020
6Biomarkers (Surrogate Marker)IBA
09/2022 - 11/2019
5Immune Checkpoint ProteinsIBA
09/2022 - 09/2020
4VaccinesIBA
04/2021 - 01/2020
4Pharmaceutical PreparationsIBA
01/2021 - 12/2019
3Monoclonal AntibodiesIBA
06/2022 - 01/2021
3Oncogene Proteins (Oncogene Protein)IBA
11/2021 - 04/2020
3LigandsIBA
11/2021 - 01/2020
3B7-H1 AntigenIBA
10/2021 - 09/2020
2Antiviral Agents (Antivirals)IBA
10/2022 - 01/2020
2Proteins (Proteins, Gene)FDA Link
09/2022 - 10/2021
2MicronutrientsIBA
08/2022 - 12/2021
2Paclitaxel (Taxol)FDA LinkGeneric
11/2021 - 10/2021
2Transcription Factors (Transcription Factor)IBA
03/2021 - 01/2021
2Fluorouracil (Carac)FDA LinkGeneric
03/2021 - 01/2021
2Cadherins (E-Cadherin)IBA
01/2021 - 01/2019
1p38 Mitogen-Activated Protein KinasesIBA
10/2022
1Janus KinasesIBA
10/2022
1Glycogen Synthase Kinase 3IBA
10/2022
1Phosphotransferases (Kinase)IBA
10/2022
1CaspasesIBA
09/2022
1Interferon-gamma (Interferon, gamma)IBA
09/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2022
1CateninsIBA
06/2022
1tremelimumabIBA
06/2022
1IpilimumabIBA
06/2022
1AntibodiesIBA
06/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2022
1VimentinIBA
01/2022
1Untranslated RNA (Noncoding RNA)IBA
01/2022
1VitaminsIBA
12/2021
1AntioxidantsIBA
12/2021
1Messenger RNA (mRNA)IBA
12/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021
1Docetaxel (Taxotere)FDA Link
10/2021
1Biological ProductsIBA
10/2021
1Blocking AntibodiesIBA
08/2021
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
08/2021
1Caspase 9IBA
04/2021
1Caspase 3 (Caspase-3)IBA
04/2021
1CytokinesIBA
03/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021
1CTLA-4 AntigenIBA
01/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2021
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2021
1Growth Differentiation Factor 15IBA
01/2021
1RNA (Ribonucleic Acid)IBA
01/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021
1FibrinolysinFDA Link
10/2020
1EnzymesIBA
10/2020
1PlasminogenIBA
10/2020
1Fibrinolytic Agents (Antithrombotic Agents)IBA
10/2020

Therapy/Procedure

18Therapeutics
10/2022 - 03/2019
16Immunotherapy
09/2022 - 01/2019
11Drug Therapy (Chemotherapy)
10/2021 - 03/2019
2Radiotherapy
01/2020 - 03/2019
1Cell- and Tissue-Based Therapy (Cell Therapy)
05/2022